Salve the World

by swisscham in Hospitality, Retail, Tourism

Traditional Chinese medicine, or TCM, is now gaining in popularity in Western markets due to the increasing demand for a more modern and nature-friendly lifestyle. Last November, Nestle Health Science, a fully owned subsidiary of Nestle SA, and Chi-Med, the pharmaceutical and healthcare subsidiary of Hong Kong-based Hutchison Whampoa Ltd, agreed to form a 50-50 joint venture to research, develop, manufacture and market innovative nutritional and medicinal products derived from plants. In 2009, Switzerland-based Novartis AG announced TCM-related R&D in China and plans to spend RMB 500 million (USD 80 million) to merge and acquire Chinese TCM enterprises in the coming years.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Switzerland Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
July 28, 2022
Published By nestle.com in Hospitality / Tourism / Retail
July 27, 2022
Published By reuters.com in Bank / Finance / Insurance
July 13, 2022
Published By swissinfo.ch in Legal / Tax / Consulting / Services
July 13, 2022
Published By mumnet.com in Hospitality / Tourism / Retail